Production of GPCR and GPCR complexes for structure determination.
暂无分享,去创建一个
[1] Michel Bouvier,et al. Restructuring G-Protein- Coupled Receptor Activation , 2012, Cell.
[2] H. Weinstein,et al. Why GPCRs behave differently in cubic and lamellar lipidic mesophases , 2012, Journal of the American Chemical Society.
[3] Xavier Deupi,et al. Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II , 2011, Proceedings of the National Academy of Sciences.
[4] W. Tanner,et al. Specific lipid requirements of membrane proteins--a putative bottleneck in heterologous expression. , 2003, Biochimica et biophysica acta.
[5] Christopher G Tate,et al. A crystal clear solution for determining G-protein-coupled receptor structures. , 2012, Trends in biochemical sciences.
[6] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[7] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[8] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[9] A. Plückthun,et al. Maximizing detergent stability and functional expression of a GPCR by exhaustive recombination and evolution. , 2012, Journal of molecular biology.
[10] D. Veprintsev,et al. Insights into congenital stationary night blindness based on the structure of G90D rhodopsin , 2013, EMBO reports.
[11] S. Opella,et al. Structure of the Chemokine Receptor CXCR1 in Phospholipid Bilayers , 2012, Nature.
[12] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[13] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[14] Brian K. Kobilka,et al. N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor , 2012, PloS one.
[15] Martin Heck,et al. Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit , 2007, Proceedings of the National Academy of Sciences.
[16] A. Engel,et al. The rhodopsin-transducin complex houses two distinct rhodopsin molecules. , 2013, Journal of structural biology.
[17] Philip J. Reeves,et al. Structure and function in rhodopsin: A tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[19] S. Iwata,et al. G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody , 2011, Nature.
[20] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[21] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[22] K. Palczewski,et al. Rhodopsin-transducin heteropentamer: three-dimensional structure and biochemical characterization. , 2011, Journal of structural biology.
[23] K. Palczewski,et al. Phospholipids are needed for the proper formation, stability, and function of the photoactivated rhodopsin-transducin complex. , 2009, Biochemistry.
[24] A. Engel,et al. Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[26] Christopher G. Tate,et al. The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.
[27] Albert C. Pan,et al. Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.
[28] Christopher G. Tate,et al. Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol , 2012, Structure.
[29] J. Shiloach,et al. Structure of the agonist-bound neurotensin receptor , 2012, Nature.
[30] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[31] Cheng Zhang,et al. High-resolution Crystal Structure of Human Protease-activated Receptor 1 Bound to the Antagonist Vorapaxar Hhs Public Access , 2022 .
[32] G. Heijne,et al. GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae , 2008, Nature Protocols.
[33] B. Kobilka,et al. Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. , 2010, Physiology.
[34] Jonathan A. Javitch,et al. Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.
[35] Cheng Zhang,et al. Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.
[36] R. Stevens,et al. LCP-Tm: an assay to measure and understand stability of membrane proteins in a membrane environment. , 2010, Biophysical journal.
[37] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[38] A. Desmyter,et al. Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems , 2007, Journal of Structural and Functional Genomics.
[39] Gebhard F. X. Schertler,et al. Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.
[40] Tong Liu,et al. Structural flexibility of the Gαs α-helical domain in the β2-adrenoceptor Gs complex , 2011, Proceedings of the National Academy of Sciences.
[41] R. Stroud,et al. Efficient expression screening of human membrane proteins in transiently transfected Human Embryonic Kidney 293S cells. , 2011, Methods.
[42] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[43] Joshua M. Kunken,et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. , 2012, Structure.
[44] R. Stevens,et al. GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.
[45] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[46] M. Caffrey,et al. Crystallizing Membrane Proteins in Lipidic Mesophases. A Host Lipid Screen. , 2011, Crystal growth & design.
[47] Jianyun Huang,et al. Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.
[48] Martin Caffrey,et al. Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. , 2012, Biochemistry.
[49] Gebhard F. X. Schertler,et al. The structural basis of agonist-induced activation in constitutively active rhodopsin , 2011, Nature.
[50] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[51] H. Khorana,et al. Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[52] Yoko Shibata,et al. Thermostabilisation of the neurotensin receptor NTS1 , 2009, Journal of molecular biology.
[53] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[54] R. Stroud,et al. Overexpressing human membrane proteins in stably transfected and clonal human embryonic kidney 293S cells , 2012, Nature Protocols.
[55] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[56] D. Oprian,et al. Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.
[57] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[58] Brian K. Kobilka,et al. Structural Instability of a Constitutively Active G Protein-coupled Receptor , 1997, The Journal of Biological Chemistry.
[59] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[60] C. Tate,et al. Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor , 2011, Journal of molecular biology.
[61] S. Iwata,et al. Platform for the rapid construction and evaluation of GPCRs for crystallography in Saccharomyces cerevisiae , 2012, Microbial Cell Factories.
[62] D. Oprian,et al. Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin. , 2011, Biochemistry.
[63] Eric Gouaux,et al. Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. , 2006, Structure.
[64] Virgil L. Woods,et al. Conformational changes in the G protein Gs induced by the β2 adrenergic receptor , 2011, Nature.
[65] Hugh Rosen,et al. Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.
[66] R. Stevens,et al. Development of an Automated High Throughput LCP-FRAP Assay to Guide Membrane Protein Crystallization in Lipid Mesophases. , 2011, Crystal growth & design.
[67] Yoko Shibata,et al. Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form , 2008, Proceedings of the National Academy of Sciences.
[68] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[69] R. Stevens,et al. Profiling of membrane protein variants in a baculovirus system by coupling cell-surface detection with small-scale parallel expression. , 2007, Protein expression and purification.
[70] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[71] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[72] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[73] A. Leslie,et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.